KANE BIOTECH INC (KNE.CA) Stock Price, Quote, News and Overview
TSX-V:KNE - TSX Venture Exchange - CA4838092084 - Common Stock - Currency: CAD
KNE.CA Quote, Performance and Key Statistics
TSX-V:KNE (3/7/2025, 7:00:00 PM)
0.095
-0.01 (-5%)
The current stock price of KNE.CA is 0.095 CAD. In the past month the price decreased by -13.64%. In the past year, price decreased by -5%.
KNE.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 270.34M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 214.26M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 202.17M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 101.16M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 84.29M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 79.22M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 77.44M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 14.18 | 66.08M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 38.5 | 54.80M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 49.83M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 46.66M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 20.78M |
Related stock screener links
About KNE.CA
Company Profile
Kane Biotech, Inc. is a biotechnology company, which engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company is headquartered in Winnipeg, Manitoba. The company went IPO on 2003-05-07. The firm has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The firm's other biofilm disruption technology is DispersinB.
Company Info
KANE BIOTECH INC
290-100 Innovation Drive
Winnipeg MANITOBA R3T 2N2 CA
CEO: Marc Edwards
Employees: 0
Company Website: https://kanebiotech.com/
Investor Relations: http://ir.kanebiotech.com/
Phone: 12044531301
KANE BIOTECH INC / KNE.CA FAQ
What is the stock price of KANE BIOTECH INC today?
The current stock price of KNE.CA is 0.095 CAD. The price decreased by -5% in the last trading session.
What is the ticker symbol for KANE BIOTECH INC stock?
The exchange symbol of KANE BIOTECH INC is KNE and it is listed on the TSX Venture Exchange exchange.
On which exchange is KNE.CA stock listed?
KNE.CA stock is listed on the TSX Venture Exchange exchange.
What is KANE BIOTECH INC worth?
KANE BIOTECH INC (KNE.CA) has a market capitalization of 12.52M CAD. This makes KNE.CA a Nano Cap stock.
How many employees does KANE BIOTECH INC have?
KANE BIOTECH INC (KNE.CA) currently has 0 employees.
What are the support and resistance levels for KANE BIOTECH INC (KNE.CA) stock?
KANE BIOTECH INC (KNE.CA) has a resistance level at 0.1. Check the full technical report for a detailed analysis of KNE.CA support and resistance levels.
Should I buy KANE BIOTECH INC (KNE.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of KNE.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of KNE.CA, evaluating the profitability, health, valuation and growth aspects
- KANE BIOTECH INC (KNE.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- KANE BIOTECH INC (KNE.CA) Sales and EPS estimates to see what analysts future expectations are.
- KANE BIOTECH INC (KNE.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- KANE BIOTECH INC (KNE.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- KANE BIOTECH INC (KNE.CA) Stock Chart to make your own analysis
- KANE BIOTECH INC (KNE.CA) Latest news and press-releases to stay up to date.
Does KANE BIOTECH INC (KNE.CA) stock pay dividends?
KNE.CA does not pay a dividend.
When does KANE BIOTECH INC (KNE.CA) report earnings?
KANE BIOTECH INC (KNE.CA) will report earnings on 2025-04-01.
What is the Price/Earnings (PE) ratio of KANE BIOTECH INC (KNE.CA)?
The PE ratio for KANE BIOTECH INC (KNE.CA) is 9.5. This is based on the reported non-GAAP earnings per share of 0.01 and the current share price of 0.095 CAD. Check the full fundamental report for a full analysis of the valuation metrics for KNE.CA.
KNE.CA Technical Analysis
KNE.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to KNE.CA. KNE.CA may be in some trouble as it scores bad on both profitability and health.
KNE.CA Financial Highlights
Over the last trailing twelve months KNE.CA reported a non-GAAP Earnings per Share(EPS) of 0.01. The EPS increased by 122.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 105.28% | ||
| ROA | 56.72% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |